NSCLC brain metastasis survival prediction method patent granted
Summary
USPTO granted patent US12594024B2 on April 7, 2026, to THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION for a method of predicting survival of non-small cell lung cancer patients with brain metastasis. The patent covers comparing patient TMTrg values against cut-off values for long-term survival prediction using medical imaging analysis.
What changed
USPTO granted patent US12594024B2 to Catholic University of Korea IAC Foundation for a method of predicting survival of non-small cell lung cancer (NSCLC) patients with brain metastasis by comparing patient TMTrg values against cut-off values for long-term survival prediction. The patent (3 claims) covers a diagnostic method involving medical imaging analysis.
Competitors developing cancer diagnostic or survival prediction methods should review this patent for potential IP implications. The granted patent may restrict development of similar survival prediction methods without license, affecting companies in oncology diagnostics and cancer research technology.
What to do next
- Monitor for patent landscape implications in cancer diagnostics
- Review freedom to operate for survival prediction methods
- Consider licensing options if developing similar diagnostic methods
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Method for predicting survival of non small cell lung cancer patients with brain metastasis
Grant US12594024B2 Kind: B2 Apr 07, 2026
Assignee
THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
Inventors
Seung Ho Yang, Young Il Kim, Hyun Ho Kim
Abstract
The present invention relates to a method for predicting survival of non-small cell lung cancer patients with brain metastasis. More specifically, it proposes a method that is useful for predicting the survival of the patients by comparing TMTrg of the patients with cut off value for predicting long term survival.
CPC Classifications
A61B 5/4519 A61B 5/055 A61B 5/0042 A61B 5/0803 A61B 5/7275 G06T 7/60 G06T 2207/10088 G06T 2207/30016
Filing Date
2024-03-28
Application No.
18620652
Claims
3
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.